FDA Approves First Generic Version of Zocor
The US Food and Drug Administration (Rockville, MD) approved the first generic versions of "Zocor" (simvastatin), the anticholesterol drug by Merck & Co., Inc. (Whitehouse Station, NJ).
The US Food and Drug Administration (Rockville, MD, www.fda.gov) approvedthe first generic version of "Zocor" (simvastatin), the anticholesteroldrug by Merck & Co., Inc. (Whitehouse Station, NJ, www.merck.com).
Simvastatin tablets (5, 10, 20, and 40 mg) are manufactured by IvaxPharmaceuticals, Inc., a wholly owned subsidiary of Teva PharmaceuticalIndustries Limited (Petach Tikva, Israel, www.tevapharm.com).Simvastatin tablets (80 mg) are manufactured by RanbaxyPharmaceuticals, Inc, the US arm of Ranbaxy Laboratories Limited.(Gurgaon, Haryana, India, www.ranbaxy.com).
Merck's US marketing exclusivity for Zocor expired in June 2006. Zocorposted 2005 sales of $4.4 billion, a 16% decline from 2004, as salesoutside of the US were affected by the availability of genericsimvastatin.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
